Modification of MHC Anchor Residues Generates Heteroclitic Peptides That Alter TCR Binding and T Cell Recognition
- 15 August 2010
- journal article
- research article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 185 (4), 2600-2610
- https://doi.org/10.4049/jimmunol.1000629
Abstract
Improving T cell Ags by altering MHC anchor residues is a common strategy used to enhance peptide vaccines, but there has been little assessment of how such modifications affect TCR binding and T cell recognition. In this study, we use surface plasmon resonance and peptide–MHC tetramer binding at the cell surface to demonstrate that changes in primary peptide anchor residues can substantially and unpredictably alter TCR binding. We also demonstrate that the ability of TCRs to differentiate between natural and anchor-modified heteroclitic peptides distinguishes T cells that exhibit a strong preference for either type of Ag. Furthermore, we show that anchor-modified heteroclitic peptides prime T cells with different TCRs compared with those primed with natural Ag. Thus, vaccination with heteroclitic peptides may elicit T cells that exhibit suboptimal recognition of the intended natural Ag and, consequently, impaired functional attributes in vivo. Heteroclitic peptide-based immune interventions therefore require careful evaluation to ensure efficacy in the clinic.Keywords
This publication has 63 references indexed in Scilit:
- Germ Line-governed Recognition of a Cancer Epitope by an Immunodominant Human T-cell ReceptorJournal of Biological Chemistry, 2009
- Engineering the binding properties of the T cell receptor:peptide:MHC ternary complex that governs T cell activityMolecular Immunology, 2009
- Tricks with tetramers: how to get the most from multimeric peptide–MHCImmunology, 2009
- Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptorNature Medicine, 2008
- Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramersJournal of Immunological Methods, 2008
- Unmodified self antigen triggers human CD8 T cells with stronger tumor reactivity than altered antigenProceedings of the National Academy of Sciences of the United States of America, 2008
- Structures of MART-126/27–35 Peptide/HLA-A2 Complexes Reveal a Remarkable Disconnect between Antigen Structural Homology and T Cell RecognitionJournal of Molecular Biology, 2007
- Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant regionEuropean Journal of Immunology, 2007
- Cancer Regression in Patients After Transfer of Genetically Engineered LymphocytesScience, 2006
- T-cell antigen receptor genes and T-cell recognitionNature, 1988